Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.53% | 170.20 | 0.7% | $964.07m | |
| ABBV | AbbVie, Inc. | 1.67% | 140.34 | 1.9% | $841.79m | |
| PFE | Pfizer Inc. | 0.61% | 49.57 | 0.9% | $830.12m | |
| LLY | Eli Lilly & Co. | 0.39% | 302.50 | 1.1% | $749.11m | |
| MRK | Merck & Co., Inc. | 1.24% | 88.49 | 0.7% | $749.03m | |
| BMY | Bristol-Myers Squibb Co. | 2.33% | 73.80 | 1.0% | $664.96m | |
| SIGA | SIGA Technologies, Inc. | -4.76% | 22.19 | 0.0% | $393.19m | |
| AZN | AstraZeneca Plc | -1.38% | 65.12 | 1.0% | $376.21m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 5.56% | 230.74 | 8.1% | $254.69m | |
| GSK | GSK Plc | -0.64% | 40.31 | 0.3% | $216.46m | |
| HZNP | Horizon Therapeutics Plc | 0.07% | 69.65 | 5.4% | $197.93m | |
| SGEN | Seagen Inc. | 1.43% | 178.33 | 5.7% | $191.45m | |
| NVS | Novartis AG | 0.43% | 85.94 | 0.2% | $174.13m | |
| RGEN | Repligen Corp. | 1.70% | 250.46 | 6.7% | $158.40m | |
| NVO | Novo Nordisk A/S | -0.76% | 102.42 | 0.1% | $151.74m |
Company Profile
CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.